Pediatric, Adolescent and Young Adult Urologic Oncology Conference
The Pediatric, Adolescent and Young Adult Urologic Oncology Conference is an opportunity for urology physicians and fellows to expand their understanding and education in the evaluation, diagnosis and treatment of this specialized area. Pediatric urologic oncology has traditionally been considered a minute aspect of routine pediatric oncology, however, recent reviews of pediatric urology practice demonstrates the proportion dedicated to oncology is more widespread than provided in traditional education in fellowship training.
Over the course of this two day conference, learners will better understand and assess the management of oncology issues in pediatric urology practice, evaluate standards of care for children, adolescents and young adults with urologic malignancy, and improve comprehension of current surgical guideline competence with a focused review of current National Comprehensive Cancer Network, American Urological Association and Children’s Oncology Group guidelines.
This education program is primarily oriented towards pediatric urology fellows, but is also open to pediatric urologists, urologic oncologists, pediatric surgeons, urology residents, and pediatric oncologists.
At the conclusion of this conference, participants should be able to:
- Discuss current standards of care in diagnosis of pediatric urologic cancers.
- Evaluate currently available clinical trials for patients with pediatric urologic cancers.
- Explore ongoing research in the realm of pediatric urologic cancers.
|Friday, June 3, 2022|
|Basics & Background|
|Case Presentations & Videos: Radical Nephrectomy, Partial Nephrectomy, LN Dissection, Minimally Invasive Surgery, and Late Effects|
|Adjourn Day 1|
|Saturday, June 4, 2022|
Bladder & Prostate Session I
Bladder & Prostate Session II
Testis/Para-testis Session I
Testis/Para-testis Session II
|Evaluation Overview & Adjourn|
We are excited to host a hybrid learning format for the Pediatric, Adolescent and Young Adult Urologic Oncology Conference! The live portion of this event is being held from Friday, June 3rd - Saturday, June 4th at the Hyatt Regency of Aurora Conference Center in Conference Room I.
The after-hours reception on June 3, 2022 will be hosted in the Borealis Patio.
Virtual attendees will receive a Zoom link to join the conference prior to the start of the event.
Pediatric, Adolescent and Young Adulty Urologic Oncology Conference is happy to offer this education for all Children's Hospital Colorado physicians and fellows, University of Colorado employees and urologic physicians and fellows across the country.
For the comfort and convenience of out-of-town learners, we have a limited number of rooms reserved at the Hyatt Regency. Hotel accommodations are complimentary for urology fellows and offered at a discounted rate for physicians - please select your preference when registering for this event.
To book your stay directly or if you have any questions regarding hotel accommodations, please either contact Jade Freeman at firstname.lastname@example.org or reach out directly to Hyatt Regency - Aurora Denver by calling 303-365-1234.
Rodrigo Romao, MD, MSc is an Associate Professor of Surgery and Urology and the Program Director for the Pediatric General Surgery fellowship program at the IWK Health Centre, Dalhousie University in Halifax, Nova Scotia, Canada. He received training in General Surgery, Pediatric General Surgery and Pediatric Urology at the University of Sao Paulo, Brazil and Sick Kids in Toronto. Dr. Romao is the Children’s Oncology Group (COG) Surgical PI for the IWK Health Centre and is also a member of the COG Renal Tumors Committee. Dr. Romao has a strong interest in pediatric surgical oncology, both clinically and from a research perspective. He is also a member of the Executive Committee of the Pediatric Uro-Oncology Working Group (PUOWG).
Margarett Shnorhavorian, MD, MPH, FAAP, FACS is a Full Professor in the Department of Urology at the University of Washington in the Division of Pediatric Urology and Affiliate Investigator in the Epidemiology Program at the Fred Hutchinson Cancer Research Center. Her research program has focused on adolescent and young adult survivorship and her clinical niche is in pediatric urologic reconstruction. Dr. Shnorhavorian is the Principal Investigator for a five-year NIH R01 level grant leading a multi-disciplinary team and has a record of accomplishment of successful collaborations on extramurally funded grants. Within COG she serves on the Steering Committee for the Survivorship and Outcomes Committee.
Jonathan Routh, MD, MPH is the Paul H. Sherman Associate Professor of Surgery (Urology), Pediatrics, and Population Health at Duke University School of Medicine, where he serves as the Chief of the Center for Children’s Surgery. He has been a member of the Society for Pediatric Urology Oncology Working Group’s Executive Committee since 2011, and was recently elected as the PUOWG President. He is an active member of the Children’s Oncology Group (COG), serving on the Soft Tissue Sarcoma committee, Surgery committee, ARST1431 Intermediate Risk Rhabdomyosarcoma study committee, and the Urinary Tract and Endocrine Task Forces of the COG Long-Term Follow-up committee. Internationally, he is a past member of the Nephrotoxicity Core of the International Guidelines Harmonization Group (IGHG) and currently serves on the Paratesticular and Bladder/Prostate Working Groups of the International Soft Tissue Sarcoma Consortium (INSTrUCT).
Nicholas Cost, MD
Kathleen Kieran, MD
Jonathan Ross, MD
Amanda Saltzman, MD
Duncan Wilcox, MD
The following financial relationships have been disclosed by faculty. All relevant financial relationships have been mitigated prior to the activity.
- Amanda Saltzman, MD: Consultant for Ethicon
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.
Children’s Hospital Colorado is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Children’s Hospital Colorado designates this live activity for a maximum of 10.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Note: A general certificate of attendance will be available after the completion of the online evaluation. Claim only credit commensurate of your conference attendance.
- 10.25 AMA PRA Category 1 Credit™
- 10.25 Attendance